Medios AG 0QB4.L Stock
Medios AG Price Chart
Medios AG 0QB4.L Financial and Trading Overview
Medios AG stock price | 15.26 EUR |
Previous Close | 17.84 EUR |
Open | 17.8 EUR |
Bid | 0 EUR x 0 |
Ask | 0 EUR x 0 |
Day's Range | 17.8 - 17.8 EUR |
52 Week Range | 16.5 - 30.1 EUR |
Volume | 176 EUR |
Avg. Volume | 2.34K EUR |
Market Cap | 2.58M EUR |
Beta (5Y Monthly) | 1.23295 |
PE Ratio (TTM) | 0.39467847 |
EPS (TTM) | 0.45 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
0QB4.L Valuation Measures
Enterprise Value | 411.34M EUR |
Trailing P/E | 0.39467847 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.0015660815 |
Price/Book (mrq) | 0.94822073 |
Enterprise Value/Revenue | 0.249 |
Enterprise Value/EBITDA | 8.377 |
Trading Information
Medios AG Stock Price History
Beta (5Y Monthly) | 1.23295 |
52-Week Change | -31.97% |
S&P500 52-Week Change | 20.43% |
52 Week High | 30.1 EUR |
52 Week Low | 16.5 EUR |
50-Day Moving Average | 18.22 EUR |
200-Day Moving Average | 18.95 EUR |
0QB4.L Share Statistics
Avg. Volume (3 month) | 2.34K EUR |
Avg. Daily Volume (10-Days) | 4.05K EUR |
Shares Outstanding | 13.66M |
Float | 15.04M |
Short Ratio | N/A |
% Held by Insiders | 37.72% |
% Held by Institutions | 29.93% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | N/A |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 1.09% |
Operating Margin (ttm) | 1.81% |
Gross Margin | 6.52% |
EBITDA Margin | 2.97% |
Management Effectiveness
Return on Assets (ttm) | 3.03% |
Return on Equity (ttm) | 4.09% |
Income Statement
Revenue (ttm) | 1.65B EUR |
Revenue Per Share (ttm) | 69.33 EUR |
Quarterly Revenue Growth (yoy) | 9.70% |
Gross Profit (ttm) | 105.83M EUR |
EBITDA | 49.11M EUR |
Net Income Avi to Common (ttm) | 18.12M EUR |
Diluted EPS (ttm) | 0.451 |
Quarterly Earnings Growth (yoy) | -4.10% |
Balance Sheet
Total Cash (mrq) | 60.73M EUR |
Total Cash Per Share (mrq) | 2.52 EUR |
Total Debt (mrq) | 45.73M EUR |
Total Debt/Equity (mrq) | 10.09 EUR |
Current Ratio (mrq) | 2.945 |
Book Value Per Share (mrq) | 18.772 |
Cash Flow Statement
Operating Cash Flow (ttm) | 14.31M EUR |
Levered Free Cash Flow (ttm) | 13.6M EUR |
Profile of Medios AG
Country | United Kingdom |
State | N/A |
City | Berlin |
Address | Heidestrasse 9 |
ZIP | 10557 |
Phone | 49 30 232 5668 00 |
Website | https://www.medios.ag |
Industry | |
Sector(s) | |
Full Time Employees | 546 |
Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment includes cytostatic infusion preparations, antibody therapies, virostatic and antibiotic medications, parenteral nutrition solutions, and investigational medicinal products. The company was founded in 2016 and is headquartered in Berlin, Germany.
Q&A For Medios AG Stock
What is a current 0QB4.L stock price?
Medios AG 0QB4.L stock price today per share is 15.26 EUR.
How to purchase Medios AG stock?
You can buy 0QB4.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Medios AG?
The stock symbol or ticker of Medios AG is 0QB4.L.
How many shares does Medios AG have in circulation?
The max supply of Medios AG shares is 145.18K.
What is Medios AG Price to Earnings Ratio (PE Ratio)?
Medios AG PE Ratio is 0.33835920 now.
What was Medios AG earnings per share over the trailing 12 months (TTM)?
Medios AG EPS is 0.45 EUR over the trailing 12 months.